This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Sebastian Hoerner, Ph.D.
Senior Scientist at BiconY Therapeutics


Sebastian Hörner received his PhD in immunology from the University of Tübingen and worked as a postdoc at the German Cancer Research Center (DKFZ). In 2023, BiconY Therapeutics was founded as a spin-off company of the two institutions and Sebastian Hörner joined as Senior Scientist. He focuses on the discovery and characterization of novel costimulatory antibodies.

Agenda Sessions

  • Two Targets, Two Signals: A Combinatorial Concept for Cancer Therapy with Bispecific Antibodies Directed to CD3 and CD28